Cargando…

The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer

BACKGROUND: Substantial evidence supports the use of inexpensive β-AR antagonists (beta blockers) against a variety of cancers, and the β-AR antagonist propranolol was recently approved by the European Medicines Agency for the treatment of soft tissue sarcomas. Prospective and retrospective data pub...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montoya, Alexa, Varela-Ramirez, Armando, Dickerson, Erin, Pasquier, Eddy, Torabi, Alireza, Aguilera, Renato, Nahleh, Zeina, Bryan, Brad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chang Gung University 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717753/ https://www.ncbi.nlm.nih.gov/pubmed/31466709 http://dx.doi.org/10.1016/j.bj.2019.02.003

Ejemplares similares

Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma
por: Wolter, Jennifer K, et al.
Publicado: (2013)

5-HT serotonin receptors modulate mitogenic signaling and impact tumor cell viability
por: Ballou, Yessenia, et al.
Publicado: (2018)

Propranolol and breast cancer—a work in progress
por: Pantziarka, Pan, et al.
Publicado: (2018)

Dermatopathic Lymphadenitis Mimicking Breast Cancer with Lymphatic Metastasis: A Case Report and Discussion
por: Alkourbah, Yamama, et al.
Publicado: (2017)

Use of non-selective β-blockers is associated with decreased tumor proliferative indices in early stage breast cancer
por: Montoya, Alexa, et al.
Publicado: (2016)

Beta Adrenergic Signaling: A Targetable Regulator of Angiosarcoma and Hemangiosarcoma
por: Dickerson, Erin B., et al.
Publicado: (2015)

The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study
por: Porcelli, Letizia, et al.
Publicado: (2020)

Propranolol, a β-adrenergic antagonist, attenuates the decrease in trabecular bone mass in high calorie diet fed growing mice
por: Baek, Kyunghwa, et al.
Publicado: (2014)

Targeted therapy with propranolol and metronomic chemotherapy combination: sustained complete response of a relapsing metastatic angiosarcoma
por: Banavali, Shripad, et al.
Publicado: (2015)

Interaction between Antagonist of Cannabinoid Receptor and Antagonist of Adrenergic Receptor on Anxiety in Male Rat
por: Komaki, Alireza, et al.
Publicado: (2014)

Multicentric Castleman’s Disease and Kaposi’s Sarcoma in a HIV-Positive Patient on Highly Active Antiretroviral Therapy
por: Ortega, Lauro, et al.
Publicado: (2014)

Differential Apoptotic and Mitogenic Effects of Lectins in Zebrafish
por: Wang, Kaidi, et al.
Publicado: (2019)

Blockade of β-Adrenergic Receptors by Propranolol Disrupts Reconsolidation of Drug Memory and Attenuates Heroin Seeking
por: Chen, Liangpei, et al.
Publicado: (2021)

Beta adrenergic antagonists and antianginal drugs
por: Stever, Lindsey M., et al.
Publicado: (2021)

Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation
por: Munabi, Naikhoba C.O., et al.
Publicado: (2016)

Propranolol Sensitizes Vascular Sarcoma Cells to Doxorubicin by Altering Lysosomal Drug Sequestration and Drug Efflux
por: Saha, Jhuma, et al.
Publicado: (2021)

β2-adrenergic receptor expression and the effects of norepinephrine and propranolol on various head and neck cancer subtypes
por: Kwon, Soon Young, et al.
Publicado: (2021)

Beta 2 Adrenergic Receptor Antagonist Propranolol and Opioidergic Receptor Antagonist Naltrexone Produce Synergistic Effects on Breast Cancer Growth Prevention by Acting on Cancer Cells and Immune Environment in a Preclinical Model of Breast Cancer
por: Murugan, Sengottuvelan, et al.
Publicado: (2021)

Beta-Adrenergic Antagonist Tolerance in Amyloid Cardiomyopathy
por: Ramsell, Stuart, et al.
Publicado: (2022)

Effects of Propranolol, a β-noradrenergic Antagonist, on Memory Consolidation and Reconsolidation in Mice
por: Villain, Hélène, et al.
Publicado: (2016)

Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment
por: Pasquier, Eddy, et al.
Publicado: (2011)

Optical control of the β(2)-adrenergic receptor with opto-prop-2: A cis-active azobenzene analog of propranolol
por: Bosma, Reggie, et al.
Publicado: (2022)

Regression of primary cardiac angiosarcoma and metastatic nodules following propranolol as a single agent treatment
por: Galván, Dana C., et al.
Publicado: (2018)

Rap1A, Rap1B, and β-Adrenergic Signaling in Autologous HCT: A Randomized Controlled Trial of Propranolol
por: Johnson, Alexander K., et al.
Publicado: (2022)

Association between tumor mutation profile and clinical outcomes among Hispanic Latina women with triple-negative breast cancer
por: Philipovskiy, Alexander, et al.
Publicado: (2020)

Beta-adrenergic receptor antagonists and chronic heart failure in children
por: Filippo, Sylvie Di
Publicado: (2007)

QSPR analysis of some agonists and antagonists of α-adrenergic receptors
por: Kawczak, Piotr, et al.
Publicado: (2014)

Correction: Regression of primary cardiac angiosarcoma and metastatic nodules following propranolol as a single agent treatment
por: Galván, Dana C., et al.
Publicado: (2019)

Beta-adrenergic receptors are expressed across diverse cancers
por: Rains, Steven L., et al.
Publicado: (2017)

Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study
por: Pasquier, Eddy, et al.
Publicado: (2016)

Propranolol treatment of infantile hemangioma endothelial cells: A molecular analysis
por: STILES, JESSICA, et al.
Publicado: (2012)

Propranolol Hydrochloride Buccoadhesive Tablet: Development and In-vitro Evaluation
por: Mortazavi, Seyedeh Maryam, et al.
Publicado: (2020)

Propranolol, a β-adrenoceptor antagonist, worsens liver injury in a model of non-alcoholic steatohepatitis
por: McKee, Chad, et al.
Publicado: (2013)

Rhodococcus equi venous catheter infection: a case report and review of the literature
por: Guerrero, Rosalinda, et al.
Publicado: (2011)

Searching in Mother Nature for Anti-Cancer Activity: Anti-Proliferative and Pro-Apoptotic Effect Elicited by Green Barley on Leukemia/Lymphoma Cells
por: Robles-Escajeda, Elisa, et al.
Publicado: (2013)

Role of propranolol in hemangiomas
por: Gajbhiye, Vishal, et al.
Publicado: (2011)

Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012)

Acute leukemia of ambiguous lineage with trisomy 4 as the sole cytogenetic abnormality: A case report and literature review
por: Moraveji, S., et al.
Publicado: (2014)

How to reduce your cancer risk: mechanisms and myths
por: Nahleh, Zeina, et al.
Publicado: (2011)

Characterization of β-adrenergic receptors in bovine intramuscular and subcutaneous adipose tissue: comparison of lubabegron fumarate with β-adrenergic receptor agonists and antagonists
por: Hwang, Jinhee H, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o5nohnub02kuf09l3bt48lcals